The Burden Of Clinically Significant Bleeding, Thrombocytopenia And Platelet Transfusions In Myelodysplastic Syndromes

Kathleen Pao Lynn Cheok,Rakchha Chhetri,Li Yan A. Wee, Arabelle Salvi,Simon Mcrae,David John Roxby,Deepak Singhal,Devendra K. Hiwase

BLOOD（2019）

Cited 0|Views12

No score

Abstract

Aim: Although 40-65% of myelodysplastic syndromes (MDS) patients are thrombocytopenic and require platelet transfusions, there is limited literature on the risk factors predictive of bleeding and the burden of immune mediated platelet refractoriness (PLT-R).

Translated text

Key words

platelet transfusions,myelodysplastic syndromes,thrombocytopenia,clinically significant bleeding

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined